Paul Colvin, EVP--Clinical Development at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 600 shares at $29.01 ($17K) on 2011-05-20, disclosed to the SEC on 2011-05-23.
Open-market sale of $17k PPDI by EVP--Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PPDI | SELL | 2011-05-27 | $165K | — | Filing → |